Nevro Gets Partial Block of Stimwave’s Spinal Cord Stimulation

Stimwave can’t program its spinal-cord-stimulation systems to deliver high-frequency pain therapy for the duration of a lawsuit filed by rival Nevro, a federal judge ruled.

• “Nevro has shown that it will very likely prove Stimwave infringed” a patent “and that those claims will also likely withstand Stimwave’s invalidity challenges,” U.S. District Judge Colm Connolly wrote in an opinion, filed July 24 in federal court in Wilmington, Delaware
• Spinal-cord stimulation (SCS) treats pain by delivering short electrical pulses to the spinal cord through electrical leads implanted in the bodyWhereas traditional SCS therapy delivers low-frequency stimulation (generally under 1.5 kHz) and ...